Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $18.1700 (-0.82%) ($18.1700 - $18.1900) on Tue. Nov. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.39% (three month average) | RSI | 47 | Latest Price | $18.1700(-0.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.9% a day on average for past five trading days. | Weekly Trend | ATRA declines -0.8% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) IBB(47%) ARKG(46%) ARKK(46%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.695% in a week (0% probabilities). VIXM(-40%) VXX(-28%) UNG(-16%) USO(-11%) TLT(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.695% (StdDev 3.39%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $18.07(0.55%) | 10 Day Moving Average | $17.74(2.42%) | 20 Day Moving Average | $17.51(3.77%) | To recent high | -8.6% | To recent low | 34.3% | Market Cap | $1.35b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |